Narrow search
Showing 1 - 10 of 64,297
Cover Image
A ban on "private label" generic pharmaceuticals : legal and economic context
Anis, Aslam H.; Harvard, Stephanie - In: International journal of the economics of business 22 (2015) 2, pp. 219-229
Persistent link: https://www.econbiz.de/10011405945
Cover Image
Reference pricing systems on the pharmaceutical market
Unsorg, Maximiliane - In: German economic review : GER 23 (2022) 3, pp. 403-421
Persistent link: https://www.econbiz.de/10013384327
Cover Image
Free-riding in pharmaceutical price regulation : theory and evidence
Pertile, Paolo; Gamba, Simona; Forster, Martin - 2018
Persistent link: https://www.econbiz.de/10011869307
Cover Image
Late-stage pharmaceutical R & D and pricing policies under two-stage regulation
Jobjornsson, Sebastian; Forster, Martin; Pertile, Paolo; … - 2015
Persistent link: https://www.econbiz.de/10011411614
Cover Image
An empirical analysis of the multimarket contact theory in pharmaceutical markets
Coronado, Javier; Jiménez-Martín, Sergi; Marín, Pedro L. - In: The European journal of health economics : HEPAC ; … 15 (2014) 6, pp. 623-643
Persistent link: https://www.econbiz.de/10010378606
Cover Image
Optimal price regulations in international pharmaceutical markets with generic competition
Geng, Difei; Saggi, Kamal - In: Technology transfer, foreign direct investment, and the …, (pp. 415-433). 2024
Persistent link: https://www.econbiz.de/10014431471
Cover Image
Endogenous versus exogenous generic reference pricing for pharmaceuticals
Antoñanzas Villar, Fernando; Juárez-Castelló, C. A.; … - In: International journal of health economics and management 17 (2017) 4, pp. 413-432
Persistent link: https://www.econbiz.de/10011814176
Cover Image
Price caps versus reimbursement limits : pharmaceutical regulation under market integration through parallel trade
Birg, Laura - 2019 - Revised Version March 2019
. Governments in both countries may limit prices directly via price caps or restrict third-party payer reimbursement for the drug … price cap and a reimbursement limit under certain conditions. In the destination country, parallel trade has no effect on … the level of regulation under a price cap, and it intensifies regulation under a reimbursement limit. Parallel trade may …
Persistent link: https://www.econbiz.de/10011986314
Cover Image
Late-stage pharmaceutical R&D and pricing policies under two-stage regulation
Jobjörnsson, Sebastian; Forster, Martin; Pertile, Paolo; … - In: Journal of health economics 50 (2016), pp. 298-311
Persistent link: https://www.econbiz.de/10011589153